|
RSRC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.90950000256151E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.36490000038847E-07 |
| Normal-vs-Stage2 |
2.09730000033659E-08 |
| Normal-vs-Stage3 |
2.69919975259825E-10 |
| Normal-vs-Stage4 |
1.19600000003661E-06 |
| Stage1-vs-Stage2 |
4.401600E-02 |
| Stage1-vs-Stage3 |
1.078190E-02 |
| Stage1-vs-Stage4 |
4.946800E-01 |
| Stage2-vs-Stage3 |
9.009000E-01 |
| Stage2-vs-Stage4 |
2.299600E-01 |
| Stage3-vs-Stage4 |
2.217000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.59500004501967E-09 |
| Normal-vs-AfricanAmerican |
1.397510E-02 |
| Normal-vs-Asian |
1.572110E-04 |
| Caucasian-vs-AfricanAmerican |
1.830560E-01 |
| Caucasian-vs-Asian |
3.056600E-01 |
| AfricanAmerican-vs-Asian |
5.941000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.68109997828503E-09 |
| Normal-vs-Female |
1.20669999548184E-08 |
| Male-vs-Female |
7.445000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.37800000030464E-07 |
| Normal-vs-Age(41-60Yrs) |
1.66800000034328E-07 |
| Normal-vs-Age(61-80Yrs) |
1.82370007983934E-10 |
| Normal-vs-Age(81-100Yrs) |
5.8592000000024E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.953800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.541700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.878100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.436970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.846000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.676000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.076400E-03 |
| Classical-VS-Follicular |
5.755800E-03 |
| Classical-VS-Other |
8.152400E-01 |
| Classical-VS-Normal |
3.58360000007885E-07 |
| Tall-VS-Follicular |
7.395000E-01 |
| Tall-VS-Other |
1.046380E-01 |
| Tall-VS-Normal |
6.70259999724365E-08 |
| Follicular-VS-Other |
2.940600E-01 |
| Follicular-VS-Normal |
5.39100000196413E-08 |
| Other-VS-Normal |
9.318200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.60229673552249E-11 |
| Normal-vs-N1 |
2.38289999998642E-06 |
| N0-vs-N1 |
4.592600E-01 |
|
|
